EP Patent

EP1392321A1 — Method of treating inflammatory disorders of the gastrointestinal tract using topical active corticosteroids

Assigned to Soligenix Inc · Expires 2004-03-03 · 22y expired

What this patent protects

A method of administration of an oral pharmaceutical product to patients suffering from inflammatory disorders of the gastrointestinal tract comprises orally administering to the patient at least two different dosage forms of a therapeutically effective amount of a topically acti…

USPTO Abstract

A method of administration of an oral pharmaceutical product to patients suffering from inflammatory disorders of the gastrointestinal tract comprises orally administering to the patient at least two different dosage forms of a therapeutically effective amount of a topically active corticosteroid, such as beclomethasone dipropionate (BDP).

Drugs covered by this patent

Patent Metadata

Patent number
EP1392321A1
Jurisdiction
EP
Classification
—
Expires
2004-03-03
Drug substance claim
No
Drug product claim
No
Assignee
Soligenix Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.